Tarsus Group has added onto its medical portfolio with the acquisition of BodySite Digital Health – a digital patient care management and education platform. The U.S.-based business will join the Tarsus Medical Group, enabling the division to further expand its stack of digital products delivered to healthcare professionals (HCPs) and also bolster its subscription services.

The acquisition will fast-track Tarsus Medical’s omnichannel strategy to provide digital services and products alongside its well-established program of live and virtual events and continuing medical education, particularly in the division’s American Academy of Anti-Aging Medicine (A4M) brand.

“This acquisition represents a very exciting move for Tarsus," said Tarsus Group CEO Douglas Emslie. "A key focus for us is to broaden our product range to reflect digital developments in the industries we serve."

He added, "Through this acquisition, we are seeking to leverage the Tarsus Medical reputation amongst medical professionals and our close access to the U.S. healthcare industry to further develop BodySite and enable the business to reach new customers and markets.”

A key driver in the U.S. healthcare industry has been the shift from reactive treatment to preventive medicine, with HCPs increasingly concerned with tackling patient issues before they arise and identifying precursors to inform patient care management. As a result, HCPs have also been turning to digital tools to facilitate the delivery and management of patient-based care, focused more strongly on day-to-day treatment and monitoring outside doctors’ offices and hospitals.

The pandemic has further fueled the switch to digital healthcare delivery and transformed the way patients see their doctor with many services once delivered in-person now replaced, typically more safely and effectively, by telehealth services.

BodySite, which was founded in 2010, leverages three core functionalities: a remote patient monitoring solution (RPM), telemedicine services and a robust learning management system (LMS) along with detailed care programs.

The platform’s features are highly valued by its subscribers, many of whom also relied on BodySite to continue to monitor and treat patients when the pandemic made in-person visits difficult. 

“We are thrilled to be joining Tarsus Group; this acquisition will allow us to provide even better tools and features for healthcare providers looking to make a greater impact on their patients’ health as well as improve the interactions they have with their patients each day,” said John Cummings, founder and CEO of BodySite Digital Health.

He added, “We very much look forward to working with Tarsus to integrate our existing offering into their medical ecosystem and expand our capabilities going forward to continue our mission to change for the better how doctors and their patients tackle health issues.”